Latest Stayble Therapeutics News & Updates

See the latest news and media coverage for Stayble. We track all announcements, press releases, and industry mentions in real time, all in one place.

Stayble Therapeutics (Stayble)

Clinical-stage biopharmaceutical company

Latest news about Stayble Therapeutics (Stayble)

18 November 2025 Stayble

Stayble presents Q3 report in webcast

Stayble and FinWire host the event on 19 November at 13:00.
20 August 2025 Stayble

Stayble Therapeutics announces half-year report for 2025

The report summarizes costs of 3 948 KSEK, result -3 921 KSEK and progress for STA363 towards phase 2 trial. Share issue added 4.55 MSEK.
30 June 2025 Stayble

Stayble publishes half-year report Q2 2025

The company carries out directed issue, reduces costs and prepares STA363 for phase 2 study. Operating result improves to -3.9 MSEK.
5 June 2025 Stayble

Stayble Therapeutics holds annual general meeting

The meeting approves the accounts for 2024, grants discharge of liability, re-elects the board of directors and auditor, resolves on fees and amends the articles of association. It was held on June 5, 2025.

April 30 Life Science Sweden

Distressed Gothenburg company wants to sell intangible assets

The research company Stayble Therapeutics has called an extraordinary general meeting on May 7 to decide on voluntary liquidation, alternatively continued operations.
April 20 Life Science Sweden

Stayble Therapeutics' board proposes voluntary liquidation and delisting

The shareholders in the research company Stayble Therapeutics are called to an extraordinary general meeting, also the first control meeting, on Thursday, May 7 in Gothenburg.
April 17 Life Science Sweden

UPDATED: Cash running out for Gothenburg company - calls for control meeting

The research company Stayble Therapeutics' cash is about to run out. A control balance sheet shows that the company's capital is less than half of its own share capital.
April 14 Life Science Sweden

Cash runs out for Gothenburg company - prepares control balance sheet

The research company Stayble Therapeutics' cash is about to run out, and the company has decided to prepare a control balance sheet.

Never miss news about Stayble

Track Stayble and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Discover what's making headlines across other trending companies.